Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Our unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas allow us to deliver depth and breadth in science with data and insight you can trust to progress your drug discovery programs.
Since 2000, we have generated:
• Over 650 Scientists
• Extensive, diverse scientific backgrounds
• More than 1,000 in vivo pharmacology studies completed annually
• Library of peer-reviewed publications
Access our latest posters and publications.
We can help secure funds for discovery programs